Dihydropyridine Calcium Channel Blocker class drugs

21 results
  • amlodipine and olmesartan medoxomil

    (AMLODIPINE and OLMESARTAN medoxomil)
    Macleods Pharmaceuticals Limited
    Amlodipine and olmesartan medoxomil tablets are indicated for the treatment of hypertension, either alone or in combination with other antihypertensive agents, to lower blood pressure and reduce cardiovascular event risks, including strokes and heart attacks. They may also serve as initial therapy for patients needing multiple agents.
  • amlodipine besylate

    (AMLODIPINE BESYLATE)
    Cipla USA Inc.
    Amlodipine besylate is indicated for treating hypertension to reduce the risk of cardiovascular events and for managing chronic stable angina, vasospastic angina, and angiographically documented coronary artery disease (CAD) to minimize hospitalization and the need for coronary revascularization.
  • amlodipine besylate

    (AMLODIPINE BESYLATE)
    Epic Pharma, LLC
    Amlodipine Besylate Tablets are indicated for treating hypertension, chronic stable angina, vasospastic angina, and to reduce hospitalization risk in patients with documented coronary artery disease. It can be used alone or with other antihypertensive or antianginal agents to manage cardiovascular risk.
  • amlodipine besylate and olmesartan medoxomil

    (Amlodipine besylate and Olmesartan medoxomil)
    Ajanta Pharma USA Inc.
    Amlodipine and olmesartan medoxomil tablets are indicated for hypertension treatment, either alone or with other antihypertensives, to reduce blood pressure and the risk of cardiovascular events, such as strokes and myocardial infarctions. They may be used as initial therapy for patients likely needing multiple medications to reach blood pressure goals.
  • caduet

    (amlodipine besylate and atorvastatin calcium)
    Pfizer Laboratories Div Pfizer Inc
    CADUET (amlodipine and atorvastatin) is indicated for patients requiring both hypertension management and lipid control. Amlodipine treats high blood pressure and various types of angina, while atorvastatin reduces risk of cardiovascular events and lowers LDL cholesterol in hyperlipidemia.
  • exforge hct

    (amlodipine valsartan and hydrochlorothiazide)
    Novartis Pharmaceuticals Corporation
    Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) is indicated for hypertension treatment to lower blood pressure, thereby reducing the risk of fatal and nonfatal cardiovascular events like strokes and myocardial infarctions. It is not recommended for initial hypertension therapy. Comprehensive management may require multiple medications.
  • felodipine

    (Felodipine Extended-release Tablets)
    Yiling Pharmaceutical Inc.
    Felodipine Extended-release Tablets are indicated for treating hypertension to lower blood pressure, reducing the risk of cardiovascular events like strokes and myocardial infarctions. It can be used alongside other antihypertensive drugs as part of comprehensive cardiovascular risk management, including lifestyle modifications and additional therapies.
  • katerzia

    (Amlodipine)
    Azurity Pharmaceuticals, Inc.
    KATERZIA is indicated for treating hypertension in adults and children (6+ years) to lower blood pressure, thus reducing cardiovascular event risks. It is also used for symptomatic treatment of chronic stable angina, vasospastic angina, and to decrease hospitalization and revascularization risk in patients with documented coronary artery disease.